Home | Technology News Search Engine:
|
|
|
Home: Technology News:
|
|
(IT-NEWSWIRE.COM, April 05, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of B-Cell Maturation Antigen(BCMA) Targeted Therapies in these regions, from 2013 to 2025 (forecast), covering North America Europe China Japan Southeast Asia India Access Report Details at: https://www.themarketreports.com/report/global-b-cell-maturation-antigenbcma-targeted-therapies-market-research-report-2018 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Transposagen Biopharmaceuticals Sutro Biopharma Malin Corporation Eureka Therapeutics firstVentury Equity Five Prime Therapeutics Credit Suisse Securities Dana-Farber Cancer Institute Deerfield Partners Onyx Pharmaceuticals Juno Therapeutics Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1047544 On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Bispecific Antibodies Antibody Drug Conjugates Chimeric Antigen Receptor T-Cells On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of B-Cell Maturation Antigen(BCMA) Targeted Therapies for each application, including Liver Cancer Respiratory Cancer Brain Cancer Others Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/1047544
The Market Reports
Shirish Gupta
+1-631-407-1315
web@themarketreports.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|
Technology News Headlines
|
|
|
Technology Business Video Feed
|
More Technology Video Feeds
|
|
|